This is the authors' abstract. We don't add key points for this paper.
CRISPR-Cas systems have provided revolutionary tools for genome editing. The discovery of Cas proteins with alternative activities has now enabled sensitive and robust tools for detecting nucleic acids. Recent reports harnessing these new CRISPR-Cas technologies display their potential for providing low-cost and practical diagnostic tools for pathogen and disease detection.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Dipali G. Sashital (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: